Growth Metrics

Immuneering (IMRX) Goodwill: 2021-2024

Historic Goodwill for Immuneering (IMRX) over the last 3 years, with Sep 2024 value amounting to $6.7 million.

  • Immuneering's Goodwill changed negligibly% to $6.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.7 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $6.7 million for FY2023, which is negligibly% changed negligibly from last year.
  • Per Immuneering's latest filing, its Goodwill stood at $6.7 million for Q3 2024, which was down 0.00% from $6.7 million recorded in Q2 2024.
  • Immuneering's 5-year Goodwill high stood at $6.7 million for Q4 2021, and its period low was $6.7 million during Q1 2022.
  • Its 3-year average for Goodwill is $6.7 million, with a median of $6.7 million in 2024.
  • Data for Immuneering's Goodwill shows a maximum YoY fell of 0.17% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Immuneering's Goodwill stood at $6.7 million in 2021, then declined by 0.17% to $6.7 million in 2022, then remained steady at $6.7 million in 2023, then remained steady at $6.7 million in 2024.
  • Its Goodwill stands at $6.7 million for Q3 2024, versus $6.7 million for Q2 2024 and $6.7 million for Q1 2024.